NCT03258463 (TOR) is a clinical trial of Change in Texas Law in Pregnancy Termination, sponsored by University of New Mexico.

Who is sponsoring NCT03258463?

NCT03258463 is sponsored by University of New Mexico.

What drugs are being tested in NCT03258463?

Interventions in NCT03258463: Change in Texas Law.

What condition does NCT03258463 study?

NCT03258463 studies Pregnancy Termination.

Is NCT03258463 still recruiting?

NCT03258463 is currently completed. Last updated 6 May 2023.

Last reviewed 2023-05-06 · How we verify

NCT03258463: TOR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Travelling for Rights

Completed Last updated 6 May 2023

What this trial tests

trial testing Change in Texas Law in Pregnancy Termination in 650 participants. Completed in 30 May 2020.

Timeline

10 February 2016

Primary endpoint
8 August 2018

30 May 2020

Quick facts

Lead sponsor	University of New Mexico
Status	Completed
Study type	OBSERVATIONAL
Enrollment	650
Start date	10 February 2016
Primary completion	8 August 2018
Estimated completion	30 May 2020
Sites	1 location across United States

Drugs / interventions tested

Change in Texas Law

Conditions studied

Pregnancy Termination — all drugs for Pregnancy Termination →

Sponsor

University of New Mexico

Who can join

Eligibility, female only, with Pregnancy Termination. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This will be a retrospective cohort study comparing women obtaining an abortion in New Mexico and living in Texas and women obtaining an abortion in New Mexico and living in New Mexico .

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of New Mexico trials

Trials by the same sponsor.

NCT07484906 — Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies · Phase 2 · withdrawn
NCT07506395 — Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder · Phase 1 · not yet recruiting
NCT07265973 — PREPARE: Perioperative REhabilitation Around Vaginal Prolapse RepAir Surgery for Recovery Enhancement · NA · recruiting
NCT06982443 — Wellness, Alcohol, Vitals, and Emotions · NA · recruiting
NCT06940609 — Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03258463 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of New Mexico
Last refreshed: 6 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03258463.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing